1. Home
  2. NMRA vs ZUMZ Comparison

NMRA vs ZUMZ Comparison

Compare NMRA & ZUMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • ZUMZ
  • Stock Information
  • Founded
  • NMRA 2019
  • ZUMZ 1978
  • Country
  • NMRA United States
  • ZUMZ United States
  • Employees
  • NMRA N/A
  • ZUMZ N/A
  • Industry
  • NMRA
  • ZUMZ Clothing/Shoe/Accessory Stores
  • Sector
  • NMRA
  • ZUMZ Consumer Discretionary
  • Exchange
  • NMRA Nasdaq
  • ZUMZ Nasdaq
  • Market Cap
  • NMRA 287.6M
  • ZUMZ 274.4M
  • IPO Year
  • NMRA 2023
  • ZUMZ 2005
  • Fundamental
  • Price
  • NMRA $1.13
  • ZUMZ $14.40
  • Analyst Decision
  • NMRA Buy
  • ZUMZ Hold
  • Analyst Count
  • NMRA 8
  • ZUMZ 2
  • Target Price
  • NMRA $10.14
  • ZUMZ $22.00
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • ZUMZ 340.9K
  • Earning Date
  • NMRA 03-03-2025
  • ZUMZ 03-13-2025
  • Dividend Yield
  • NMRA N/A
  • ZUMZ N/A
  • EPS Growth
  • NMRA N/A
  • ZUMZ N/A
  • EPS
  • NMRA N/A
  • ZUMZ N/A
  • Revenue
  • NMRA N/A
  • ZUMZ $889,202,000.00
  • Revenue This Year
  • NMRA N/A
  • ZUMZ $3.43
  • Revenue Next Year
  • NMRA N/A
  • ZUMZ $1.97
  • P/E Ratio
  • NMRA N/A
  • ZUMZ N/A
  • Revenue Growth
  • NMRA N/A
  • ZUMZ 1.57
  • 52 Week Low
  • NMRA $1.13
  • ZUMZ $12.67
  • 52 Week High
  • NMRA $17.19
  • ZUMZ $31.37
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 26.07
  • ZUMZ 48.60
  • Support Level
  • NMRA $1.13
  • ZUMZ $12.67
  • Resistance Level
  • NMRA $1.23
  • ZUMZ $15.29
  • Average True Range (ATR)
  • NMRA 0.12
  • ZUMZ 0.77
  • MACD
  • NMRA 0.05
  • ZUMZ 0.24
  • Stochastic Oscillator
  • NMRA 3.54
  • ZUMZ 66.03

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About ZUMZ Zumiez Inc.

Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

Share on Social Networks: